L
Lumos Diagnostics
Helps to develop and manufacture custom rapid Point-of-Care diagnostic solutions
About Lumos Diagnostics
Lumos Diagnostics specializes in developing, manufacturing, and commercializing custom rapid point of care (POC) diagnostic solutions. The company operates in the healthcare diagnostics market, serving clients ranging from healthcare providers to pharmaceutical companies. Lumos Diagnostics leverages its ISO 13485 certified manufacturing facility and co-located technical R&D team to minimize the time and risk associated with transferring products into production. This integrated approach ensures ongoing support and high-quality output.
Read full description
The business model of Lumos Diagnostics revolves around providing tailored diagnostic solutions that meet specific client needs. This includes the development of proprietary Lumos-branded POC diagnostic tests and assays, which can be configured as standalone manual read products or integrated with Lumos readers or third-party hardware for fully automated solutions. Additionally, Lumos has developed a digital technology platform that allows clients to utilize cloud-based services to create a comprehensive product ecosystem, enhancing the capability of diagnostic readers.
Lumos Diagnostics generates revenue through direct commercial sales of its proprietary diagnostic tests, custom development projects, and ongoing support services. By offering a combination of product sales and bespoke development services, the company ensures a diversified income stream.
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Jul 2026 | $3.2M | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | Apr 2026 | $0 | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lumos Diagnostics is 12K monthly website visits, up 0% over the last three months. Lumos Diagnostics's team grew 15% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Innovation Connections
Series A2 investors entered at this stage
Planet Innovation
Regal Funds Management
Other known investors5 additional known investors
Australian Unity
Ellerston Capital- PEPerennial
Soul Patts
Tenmile
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lumos Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lumos Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







